- Home
- PLCE vs ZTEK Comparison
PLCE vs ZTEK Comparison
Compare PLCE & ZTEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLCE
- ZTEK
- Stock Information
- Founded
- PLCE 1969
- ZTEK 2008
- Country
- PLCE United States
- ZTEK Canada
- Employees
- PLCE N/A
- ZTEK N/A
- Industry
- PLCE Clothing/Shoe/Accessory Stores
- ZTEK Major Chemicals
- Sector
- PLCE Consumer Discretionary
- ZTEK Industrials
- Exchange
- PLCE Nasdaq
- ZTEK Nasdaq
- Market Cap
- PLCE 76.8M
- ZTEK 103.3M
- IPO Year
- PLCE 1997
- ZTEK N/A
- Fundamental
- Price
- PLCE $6.23
- ZTEK $1.68
- Analyst Decision
- PLCE Hold
- ZTEK
- Analyst Count
- PLCE 2
- ZTEK 0
- Target Price
- PLCE $9.00
- ZTEK N/A
- AVG Volume (30 Days)
- PLCE 602.2K
- ZTEK 77.4K
- Earning Date
- PLCE 06-11-2025
- ZTEK 06-26-2025
- Dividend Yield
- PLCE N/A
- ZTEK N/A
- EPS Growth
- PLCE N/A
- ZTEK N/A
- EPS
- PLCE N/A
- ZTEK N/A
- Revenue
- PLCE $1,386,269,000.00
- ZTEK $44,936.00
- Revenue This Year
- PLCE N/A
- ZTEK N/A
- Revenue Next Year
- PLCE N/A
- ZTEK N/A
- P/E Ratio
- PLCE N/A
- ZTEK N/A
- Revenue Growth
- PLCE N/A
- ZTEK 92.38
- 52 Week Low
- PLCE $4.77
- ZTEK $0.50
- 52 Week High
- PLCE $19.74
- ZTEK $1.31
- Technical
- Relative Strength Index (RSI)
- PLCE 51.17
- ZTEK 65.54
- Support Level
- PLCE $4.81
- ZTEK $1.51
- Resistance Level
- PLCE $6.00
- ZTEK $1.83
- Average True Range (ATR)
- PLCE 0.47
- ZTEK 0.17
- MACD
- PLCE 0.17
- ZTEK 0.03
- Stochastic Oscillator
- PLCE 90.45
- ZTEK 79.44
About PLCE Children's Place Inc. (The)
Children's Place Inc operate an omni-channel children's specialty portfolio of brands in North America. It design, contract to manufacture, and sell fashionable, high-quality apparel, accessories and footwear predominantly at value prices under proprietary The Children's Place, Place, Baby Place, Gymboree, Sugar & Jade, and PJ Place brand names.
About ZTEK Zentek Ltd.
Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment. It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases.